330 related articles for article (PubMed ID: 29228994)
1. Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy.
Ma L; Qiu B; Zhang J; Li QW; Wang B; Zhang XH; Qiang MY; Chen ZL; Guo SP; Liu H
Chin J Cancer; 2017 Dec; 36(1):93. PubMed ID: 29228994
[TBL] [Abstract][Full Text] [Related]
2. The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.
Feng W; Zhang Q; Fu XL; Cai XW; Zhu ZF; Yang HJ; Xiang JQ; Zhang YW; Chen HQ
BMC Cancer; 2015 May; 15():348. PubMed ID: 25934006
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of NQO1 C609T polymorphisms after postoperative radiation therapy in completely resected non-small cell lung cancer.
Song SY; Jeong SY; Park HJ; Park SI; Kim DK; Kim YH; Shin SS; Lee SW; Ahn SD; Kim JH; Lee JS; Choi EK
Lung Cancer; 2010 May; 68(2):278-82. PubMed ID: 19596483
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is 'cured' from postoperative recurrence?
Sekihara K; Hishida T; Yoshida J; Oki T; Omori T; Katsumata S; Ueda T; Miyoshi T; Goto M; Nakasone S; Ichikawa T; Matsuzawa R; Aokage K; Goto K; Tsuboi M
Eur J Cardiothorac Surg; 2017 Sep; 52(3):522-528. PubMed ID: 28482033
[TBL] [Abstract][Full Text] [Related]
5. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
6. Post-recurrence survival analysis of stage I non-small-cell lung cancer.
Lee K; Kim HR; Kim DK; Kim YH; Park SI; Choi SH; Han J
Asian Cardiovasc Thorac Ann; 2017 Nov; 25(9):623-629. PubMed ID: 29058973
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
[TBL] [Abstract][Full Text] [Related]
8. Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer.
Shoji F; Morodomi Y; Akamine T; Takamori S; Katsura M; Takada K; Suzuki Y; Fujishita T; Okamoto T; Maehara Y
Lung Cancer; 2016 Aug; 98():15-21. PubMed ID: 27393501
[TBL] [Abstract][Full Text] [Related]
9. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer.
Sher DJ; Gielda BT; Liptay MJ; Warren WH; Batus M; Fidler MJ; Garg S; Bonomi P
Clin Lung Cancer; 2013 Jul; 14(4):370-5. PubMed ID: 23260389
[TBL] [Abstract][Full Text] [Related]
11. Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis.
Askoxylakis V; Hegenbarth P; Timke C; Saleh-Ebrahimi L; Debus J; Röder F; Huber PE
Radiat Oncol; 2016 Feb; 11():17. PubMed ID: 26847089
[TBL] [Abstract][Full Text] [Related]
12. FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancer.
Kohutek ZA; Wu AJ; Zhang Z; Foster A; Din SU; Yorke ED; Downey R; Rosenzweig KE; Weber WA; Rimner A
Lung Cancer; 2015 Aug; 89(2):115-20. PubMed ID: 26078260
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer.
Song IH; Yeom SW; Heo S; Choi WS; Yang HC; Jheon S; Kim K; Cho S
Eur J Cardiothorac Surg; 2014 Feb; 45(2):262-7. PubMed ID: 23811122
[TBL] [Abstract][Full Text] [Related]
16. Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection.
Liu YP; Li H; You R; Li JB; Liu XK; Yang AK; Guo X; Song M; Zhang Q; Guo ZM; Chen WK; Liu WW; Zou X; Hua YJ; Yang Q; Zhang YN; Sun R; Mo HY; Guo L; Lin AH; Mai HQ; Qian CN; Chen MY
Laryngoscope; 2019 Feb; 129(2):387-395. PubMed ID: 30325027
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy of radiotherapy between postoperative mediastinal lymph node recurrence and stage III disease in non-small cell lung cancer patients.
Imai H; Murakami H; Yoshino R; Mori K; Sumita K; Ono A; Akamatsu H; Taira T; Kenmotsu H; Harada H; Naito T; Kaira K; Tomizawa Y; Ohde Y; Matsuura M; Endo M; Saito R; Nakajima T; Takahashi T
J BUON; 2016; 21(2):333-40. PubMed ID: 27273942
[TBL] [Abstract][Full Text] [Related]
18. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
[TBL] [Abstract][Full Text] [Related]
19. Induction therapy followed by surgery for T3-T4/N0 non-small cell lung cancer: long-term results.
Lococo F; Cesario A; Margaritora S; Dall'Armi V; Nachira D; Cusumano G; Meacci E; Granone P
Ann Thorac Surg; 2012 May; 93(5):1633-40. PubMed ID: 22480394
[TBL] [Abstract][Full Text] [Related]
20. Salvage surgery for locoregional recurrence or persistent tumor after high dose chemoradiotherapy for locally advanced non-small cell lung cancer.
Dickhoff C; Dahele M; Paul MA; van de Ven PM; de Langen AJ; Senan S; Smit EF; Hartemink KJ
Lung Cancer; 2016 Apr; 94():108-13. PubMed ID: 26973215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
